tiprankstipranks
ProKidney (MX:PROK)
:PROK
Mexico Market
PROK
ProKidney
RESEARCH TOOLSreports

ProKidney (PROK) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

PROK Analyst Ratings

Hold
5Ratings
Hold
2 Buy
2 Hold
1 Sell
Based on 5 analysts giving stock ratings to
ProKidney
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

PROK Stock 12 Month Forecast

Average Price Target

$97.25
▲(212.68% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for ProKidney in the last 3 months. The average price target is $97.25 with a high forecast of $202.95 and a low forecast of $16.91. The average price target represents a 212.68% change from the last price of $31.10.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"15":"$15","62":"$62","109":"$109","156":"$156","203":"$203"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":202.94610084,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$202.95</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":97.24500665250001,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$97.25</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16.91217507,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$16.91</span>\n  </div></div>","useHTML":true}}],"tickPositions":[15,62,109,156,203],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,31.1,44.31893083384615,57.53786166769231,70.75679250153846,83.97572333538463,97.19465416923077,110.41358500307692,123.63251583692309,136.85144667076923,150.0703775046154,163.28930833846155,176.5082391723077,189.72717000615384,{"y":202.94610084,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,31.1,36.188077434807695,41.27615486961538,46.364232304423076,51.45230973923077,56.540387174038464,61.62846460884616,66.71654204365385,71.80461947846155,76.89269691326923,81.98077434807692,87.06885178288462,92.15692921769231,{"y":97.24500665250001,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,31.1,30.008628851538464,28.917257703076924,27.825886554615387,26.734515406153847,25.64314425769231,24.551773109230773,23.460401960769232,22.36903081230769,21.277659663846155,20.186288515384618,19.094917366923077,18.00354621846154,{"y":16.91217507,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":46.3,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.85,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":41.09,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":40.77,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":35.06,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.53,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.2,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.5,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.7,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.1,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$202.95Average Price Target$97.25Lowest Price Target$16.91
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on MX:PROK
Anupam Rama
J.P. Morgan
J.P. Morgan
―
Hold
―
Reiterated
08/13/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: ProKidney (NASDAQ: PROK), Eton Pharmaceuticals (NASDAQ: ETON) and Dyadic International (NASDAQ: DYAI)
H.C. Wainwright Analyst forecast on MX:PROK
Joseph Pantginis
H.C. Wainwright
H.C. Wainwright
$202.95
Buy
552.56%
Upside
Reiterated
08/11/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: ProKidney (NASDAQ: PROK), Crinetics Pharmaceuticals (NASDAQ: CRNX) and Alumis Inc. (NASDAQ: ALMS)
Morgan Stanley Analyst forecast on MX:PROK
Judah Frommer
Morgan Stanley
Morgan Stanley
$50.74
Hold
63.14%
Upside
Reiterated
08/11/26
ProKidney (PROK) Receives a Hold from Morgan Stanley
Guggenheim Analyst forecast on MX:PROK
Unknown Analyst
Guggenheim
Not Ranked
Guggenheim
$118.39
Buy
280.66%
Upside
Reiterated
08/10/26
ProKidney (PROK) Gets a Buy from Guggenheim
Bank of America Securities Analyst forecast on MX:PROK
Dina Ramadane
Bank of America Securities
Bank of America Securities
$16.91
Sell
-45.62%
Downside
Reiterated
08/10/26
Bank of America Securities Keeps Their Sell Rating on ProKidney (PROK)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on MX:PROK
Anupam Rama
J.P. Morgan
J.P. Morgan
―
Hold
―
Reiterated
08/13/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: ProKidney (NASDAQ: PROK), Eton Pharmaceuticals (NASDAQ: ETON) and Dyadic International (NASDAQ: DYAI)
H.C. Wainwright Analyst forecast on MX:PROK
Joseph Pantginis
H.C. Wainwright
H.C. Wainwright
$202.95
Buy
552.56%
Upside
Reiterated
08/11/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: ProKidney (NASDAQ: PROK), Crinetics Pharmaceuticals (NASDAQ: CRNX) and Alumis Inc. (NASDAQ: ALMS)
Morgan Stanley Analyst forecast on MX:PROK
Judah Frommer
Morgan Stanley
Morgan Stanley
$50.74
Hold
63.14%
Upside
Reiterated
08/11/26
ProKidney (PROK) Receives a Hold from Morgan Stanley
Guggenheim Analyst forecast on MX:PROK
Unknown Analyst
Guggenheim
Not Ranked
Guggenheim
$118.39
Buy
280.66%
Upside
Reiterated
08/10/26
ProKidney (PROK) Gets a Buy from Guggenheim
Bank of America Securities Analyst forecast on MX:PROK
Dina Ramadane
Bank of America Securities
Bank of America Securities
$16.91
Sell
-45.62%
Downside
Reiterated
08/10/26
Bank of America Securities Keeps Their Sell Rating on ProKidney (PROK)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
JAZZJazz Pharmaceuticals
AXGNAxoGen
ARDXArdelyx
ARWRArrowhead Pharmaceuticals
PTGXProtagonist Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering ProKidney

3 Months
Joseph PantginisH.C. Wainwright
Success Rate
1/6 ratings generated profit
17%
Average Return
-3.13%
Copying Joseph Pantginis's trades and holding each position for 3 Months would result in 16.67% of your transactions generating a profit, with an average return of -3.13% per trade.
1 Year
Joseph PantginisH.C. Wainwright
Success Rate
3/6 ratings generated profit
50%
Average Return
+5.22%
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +5.22% per trade.
2 Years
Joseph PantginisH.C. Wainwright
Success Rate
3/6 ratings generated profit
50%
Average Return
+5.22%
Copying Joseph Pantginis's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +5.22% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PROK Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
4
2
2
2
2
Buy
0
0
0
0
0
Hold
3
1
1
2
2
Sell
2
1
1
1
1
Strong Sell
0
0
0
0
0
total
9
4
4
5
5
In the current month, PROK has received 2 Buy Ratings, 2 Hold Ratings, and 1 Sell Ratings. PROK average Analyst price target in the past 3 months is 97.25.
Each month's total comprises the sum of three months' worth of ratings.

PROK Financial Forecast

PROK Earnings Forecast

Next quarter’s earnings estimate for PROK is -$2.60 with a range of -$4.22 to -$2.03. The previous quarter’s EPS was -$2.53. PROK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year PROK has Performed in-line its overall industry.
Next quarter’s earnings estimate for PROK is -$2.60 with a range of -$4.22 to -$2.03. The previous quarter’s EPS was -$2.53. PROK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year PROK has Performed in-line its overall industry.

PROK Sales Forecast

Next quarter’s sales forecast for PROK is $2.11M with a range of $0.00 to $3.38M. The previous quarter’s sales results were $2.53M. PROK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year PROK has Performed in-line its overall industry.
Next quarter’s sales forecast for PROK is $2.11M with a range of $0.00 to $3.38M. The previous quarter’s sales results were $2.53M. PROK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year PROK has Performed in-line its overall industry.

PROK Stock Forecast FAQ

What is MX:PROK’s average 12-month price target, according to analysts?
Based on analyst ratings, ProKidney’s 12-month average price target is 97.25.
    What is MX:PROK’s upside potential, based on the analysts’ average price target?
    ProKidney has 212.68% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ProKidney a Buy, Sell or Hold?
          ProKidney has a consensus rating of Hold, which is based on 2 buy ratings, 2 hold ratings and 1 sell ratings.
            What is ProKidney’s share price target?
            The average share price target for ProKidney is 97.25. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $202.95 ,and the lowest forecast is $16.91. The average share price target represents 212.68% Increase from the current price of $31.1.
              What do analysts say about ProKidney?
              ProKidney’s analyst rating consensus is a Hold. This is based on the ratings of 5 Wall Streets Analysts.
                How can I buy shares of ProKidney?
                To buy shares of MX:PROK, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.